Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer’s Disease

References

• Carbone LD, Johnson KC, Robbins J, et al. Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women’s health initiative (WHI). J Bone Miner Res. 2010;25(4):873–881. doi:10.1359/jbmr.09102719839772
   PubMed Web of Science ®Google Scholar
• Espinosa PS, Perez DL, Abner E, Ryan M. Association of antiepileptic drugs, vitamin D, and calcium supplementation with bone fracture occurrence in epilepsy patients. Clin Neurol Neurosurg. 2011;113(7):548–551. doi:10.1016/j.clineuro.2011.03.01121507568
   PubMed Web of Science ®Google Scholar
• Nicholas JM, Ridsdale L, Richardson MP, Grieve AP, Gulliford MC. Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database. Seizure. 2013;22(1):37–42. doi:10.1016/j.seizure.2012.10.00223127777
   PubMed Web of Science ®Google Scholar
• Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts AC. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology. 2006;66(9):1318–1324. doi:10.1212/01.wnl.0000210503.89488.8816682661
   PubMed Web of Science ®Google Scholar
• Shen C, Chen F, Zhang Y, Guo Y, Ding M. Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis. Bone. 2014;64:246–253. doi:10.1016/j.bone.2014.04.01824780876
   PubMed Web of Science ®Google Scholar
• Scherder EJ, Plooij B. Assessment and management of pain, with particular emphasis on central neuropathic pain, in moderate to severe dementia. Drugs Aging. 2012;29(9):701–706. doi:10.1007/s40266-012-0001-823018606
   PubMed Web of Science ®Google Scholar
• Lanctot KL, Amatniek J, Ancoli-Israel S, et al. Neuropsychiatric signs and symptoms of Alzheimer’s disease: new treatment paradigms. Alzheimers Dement. 2017;3(3):440–449. doi:10.1016/j.trci.2017.07.001
   Google Scholar
• Seppala LJ, Petrovic M, Ryg J, et al. STOPPFall (Screening tool of older persons prescriptions in older adults with high fall risk): a Delphi study by the EuGMS task and finish group on fall-risk-increasing drugs. Age Ageing. 2020. doi:10.1093/ageing/afaa249
   Web of Science ®Google Scholar
• Baillon SF, Narayana U, Luxenberg JS, Clifton AV. Valproate preparations for agitation in dementia. Cochrane Database Syst Rev. 2018;10:CD003945. doi:10.1002/14651858.CD003945.pub430293233
   PubMed Web of Science ®Google Scholar
• Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanctot KL. pharmacological management of agitation and aggression in Alzheimer’s disease: a review of current and novel treatments. Curr Alzheimer Res. 2016;13(10):1134–1144. doi:10.2174/156720501366616050212293327137221
   PubMed Web of Science ®Google Scholar
• Gallagher D, Herrmann N. Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy? Drugs. 2014;74(15):1747–1755. doi:10.1007/s40265-014-0293-625239267
   PubMed Web of Science ®Google Scholar
• Dolder CR, Nealy KL. The efficacy and safety of newer anticonvulsants in patients with dementia. Drugs Aging. 2012;29(8):627–637. doi:10.1007/BF0326227922734626
   PubMed Web of Science ®Google Scholar
• Watt JA, Goodarzi Z, Veroniki AA, et al. Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis. BMC Geriatr. 2020;20(1):212. doi:10.1186/s12877-020-01607-732546202
   PubMed Web of Science ®Google Scholar
• Tolppanen AM, Taipale H, Koponen M, et al. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. Pharmacoepidemiol Drug Saf. 2017;26(8):875–889. doi:10.1002/pds.423228556303
   PubMed Web of Science ®Google Scholar
• Sarycheva T, Taipale H, Lavikainen P, et al. Incidence and prevalence of antiepileptic medication use in community-dwelling persons with and without Alzheimer’s disease. J Alzheimers Dis. 2018;66(1):387–395. doi:10.3233/JAD-18059430282366
   PubMed Web of Science ®Google Scholar
• Tolppanen A-M, Lavikainen P, Soininen H, Hartikainen S. Incident hip fractures among community dwelling persons with alzheimer’s disease in a finnish nationwide register-based cohort. PLoS One. 2013;8(3):e59124. doi:10.1371/journal.pone.005912423527106
   PubMed Web of Science ®Google Scholar
• Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23(9):2239–2256. doi:10.1007/s00198-012-1964-322419370
   PubMed Web of Science ®Google Scholar
• Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513–521. doi:10.1001/jama.2009.5019190316
   PubMed Web of Science ®Google Scholar
• Klop C, van Staa TP, Cooper C, Harvey NC, de Vries F. The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity. Osteoporos Int. 2017;28(1):161–168. doi:10.1007/s00198-016-3787-027722838
   PubMed Web of Science ®Google Scholar
• Katsoulis M, Benetou V, Karapetyan T, et al. Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med. 2017;281(3):300–310. doi:10.1111/joim.1258628093824
   PubMed Web of Science ®Google Scholar
• Dahl C, Holvik K, Meyer HE, et al. Increased mortality in hip fracture patients living alone: a NOREPOS Study. J Bone Miner Res. 2021;36(3):480–488. doi:10.1002/jbmr.421233403722
   PubMed Web of Science ®Google Scholar
• Patel R, Bhimjiyani A, Ben-Shlomo Y, Gregson CL. Social deprivation predicts adverse health outcomes after hospital admission with hip fracture in England. Osteoporos Int. 2021. doi:10.1007/s00198-020-05768-4
   Web of Science ®Google Scholar
• Tajeu GS, Delzell E, Smith W, et al. Death, debility, and destitution following hip fracture. J Gerontol a Biol Sci Med Sci. 2014;69(3):346–353. doi:10.1093/gerona/glt10523873945
   PubMed Web of Science ®Google Scholar
• Tang VL, Sudore R, Cenzer IS, et al. Rates of recovery to pre-fracture function in older persons with hip fracture: an observational study. J Gen Intern Med. 2017;32(2):153–158. doi:10.1007/s11606-016-3848-227605004
   PubMed Web of Science ®Google Scholar
• Bleibler F, Rapp K, Jaensch A, Becker C, Konig HH. Expected lifetime numbers and costs of fractures in postmenopausal women with and without osteoporosis in Germany: a discrete event simulation model. BMC Health Serv Res. 2014;14(1):284. doi:10.1186/1472-6963-14-28424981316
   PubMed Web of Science ®Google Scholar
• Lambrelli D, Burge R, Raluy-Callado M, Chen SY, Wu N, Schoenfeld MJ. Retrospective database study to assess the economic impact of hip fracture in the United Kingdom. J Med Econ. 2014;17(11):817–825. doi:10.3111/13696998.2014.95958825164473
   PubMedGoogle Scholar
• Leal J, Gray AM, Prieto-Alhambra D, et al. Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int. 2016;27(2):549–558. doi:10.1007/s00198-015-3277-9
   PubMed Web of Science ®Google Scholar
• Tarride J, Adachi JD, Brown JP, Schemitsch E, Slatkovska L, Burke N. Incremental costs of fragility fractures: a population-based matched-cohort study from Ontario, Canada. Osteoporos Int. 2021. doi:10.1007/s00198-021-05877-8
   Web of Science ®Google Scholar
• Tolppanen AM, Taipale H, Koponen M, et al. Cohort profile: the Finnish medication and Alzheimer’s disease (MEDALZ) study. BMJ Open. 2016;6(7):e012100. doi:10.1136/bmjopen-2016-012100
   Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease. Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of health and human services task force on Alzheimer’s disease. Neurology. 1984;34(7):939. doi:10.1212/WNL.34.7.9396610841
   PubMed Web of Science ®Google Scholar
• Bell CC. DSM-IV: diagnostic and statistical manual of mental disorders. JAMA. 1994;272(10):828–829. doi:10.1001/jama.1994.03520100096046
   Google Scholar
• Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915–920. doi:10.1093/aje/kwg23114585769
   PubMed Web of Science ®Google Scholar
• Tanskanen A, Taipale H, Koponen M, et al. From prescription drug purchases to drug use periods - a second generation method (PRE2DUP). BMC Med Inform Decis Mak. 2015;15(1):21. doi:10.1186/s12911-015-0140-z25890003
   PubMed Web of Science ®Google Scholar
• Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S. Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons. Clin Epidemiol. 2016;8:363–371. doi:10.2147/CLEP.S11616027785101
   PubMed Web of Science ®Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. doi:10.1080/00273171.2011.56878621818162
   PubMed Web of Science ®Google Scholar
• Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–3679. doi:10.1002/sim.660726238958
   PubMed Web of Science ®Google Scholar
• Austin PC. Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score. Pharmacoepidemiol Drug Saf. 2008;17(12):1202–1217. doi:10.1002/pds.167318972454
   PubMed Web of Science ®Google Scholar
• Vajda FJ, Eadie MJ. The clinical pharmacology of traditional antiepileptic drugs. Epileptic Disord. 2014;16(4):395–408. doi:10.1684/epd.2014.070425470190
   PubMed Web of Science ®Google Scholar
• Clement ND, Court-Brown CM. Elderly pelvic fractures: the incidence is increasing and patient demographics can be used to predict the outcome. Eur J Orthop Surg Traumatol. 2014;24(8):1431–1437. doi:10.1007/s00590-014-1439-724664452
   PubMedGoogle Scholar
• Court-Brown CM, McQueen MM. Global Forum: fractures in the Elderly. J Bone Joint Surg Am. 2016;98(9):e36. doi:10.2106/JBJS.15.0079327147693
   PubMed Web of Science ®Google Scholar
• Bhandari SK, Adams AL, Li BH, et al. Sub-acute more than chronic hyponatremia is associated with serious falls and hip fractures. Intern Med J. 2019.
   Web of Science ®Google Scholar
• Vossel KA, Tartaglia MC, Nygaard HB, Zeman AZ, Miller BL. Epileptic activity in Alzheimer’s disease: causes and clinical relevance. Lancet Neurol. 2017;16(4):311–322. doi:10.1016/S1474-4422(17)30044-328327340
   PubMed Web of Science ®Google Scholar
• Sund R, Nurmi-Luthje I, Luthje P, Tanninen S, Narinen A, Keskimaki I. Comparing properties of audit data and routinely collected register data in case of performance assessment of hip fracture treatment in Finland. Methods Inf Med. 2007;46(05):558–566. doi:10.1160/ME038217938779
   PubMed Web of Science ®Google Scholar